S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Corvus PharmaceuticalsCELYAD SA/ADRAvenue TherapeuticsSavaraAduro BioTech
SymbolNASDAQ:CRVSNASDAQ:CYADNASDAQ:ATXINASDAQ:SVRANASDAQ:ADRO
Price Information
Current Price$3.00$9.88$5.43$0.87$0.99
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$8.00$36.50$10.50$8.60$9.33
% Upside from Price Target166.67% upside269.43% upside93.37% upside891.70% upside844.21% upside
Trade Information
Market Cap$85.23 million$95.15 million$89.92 million$35.73 million$84.15 million
Beta1.081.17-0.450.21.46
Average Volume131,19115,21739,449405,471532,586
Sales & Book Value
Annual RevenueN/A$3.68 millionN/A$130,000.00$15.09 million
Price / SalesN/A26.50N/A274.825.24
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.77 per share$6.65 per share($0.06) per share$3.08 per share$1.70 per share
Price / BookN/A1.49N/A0.280.58
Profitability
Net Income$-46,940,000.00$-44,200,000.00$-21,550,000.00$-61,520,000.00$-95,360,000.00
EPSN/A($3.97)($2.10)($1.29)($1.16)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-624.51%
Return on Equity (ROE)-43.50%N/A-272.04%-45.12%-68.69%
Return on Assets (ROA)-39.60%N/A-179.38%-32.97%-24.64%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.09%N/A0.22%0.32%
Current Ratio9.17%3.98%8.84%12.61%8.45%
Quick Ratio9.17%N/A8.84%12.61%8.45%
Ownership Information
Institutional Ownership Percentage82.83%7.23%8.23%41.19%41.69%
Insider Ownership Percentage40.40%N/A5.00%6.50%5.20%
Miscellaneous
Employees49N/A6N/A152
Shares Outstanding29.39 million9.87 million16.56 million41.20 million80.14 million
Next Earnings Date11/7/2019 (Estimated)N/A11/13/2019 (Estimated)11/6/2019 (Estimated)10/29/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable
 Corvus PharmaceuticalsCELYAD SA/ADRAvenue TherapeuticsSavaraAduro BioTech

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel